BRUOG-397

BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab for Patients With Resectable Stage IB - III Non-Small Cell Lung Cancer

Status:

OPEN TO ACCRUAL

Trial Type:
Age Group:
Adults
Phase:

II

NCT Number:
Contact:

Azzoli, Christopher